TMA is on a mission to improve the lives of rare patients everywhere. We help patients - providing high value comprehensive genome sequencing, reporting, and research tools to our network of more than 3.5 million patients so they can work with their Doctors to build a personalized care plan that helps their unique needs. Our rare disease database pairs deidentified medical records and genomic sequencing from diverse geographies, giving our pharma partners a competitive edge identifying patients for clinical trials and powering our research partners' efforts to advance new cures.